Found: 34
Select item for more details and to access through your institution.
Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price?
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 4, p. 227, doi. 10.1007/s40261-023-01251-0
- By:
- Publication type:
- Article
Circulating nucleosomes and response to chemotherapy: An in vitro, in vivo and clinical study on cervical cancer patients.
- Published in:
- International Journal of Cancer, 2003, v. 104, n. 6, p. 663, doi. 10.1002/ijc.11003
- By:
- Publication type:
- Article
Cytotoxic Activity and Structure–Activity Relationship of Triazole‐Containing Bis(Aryl Ether) Macrocycles.
- Published in:
- ChemMedChem, 2018, v. 13, n. 12, p. 1193, doi. 10.1002/cmdc.201800075
- By:
- Publication type:
- Article
Selection of clinically relevant drug concentrations for in vitro studies of candidates drugs for cancer repurposing: a proposal.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 5, p. 1077, doi. 10.1007/s12094-023-03352-w
- By:
- Publication type:
- Article
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study.
- Published in:
- Molecular Cancer, 2005, v. 4, p. 22, doi. 10.1186/1476-4598-4-22
- By:
- Publication type:
- Article
The combination of orlistat, lonidamine and 6-diazo-5-oxo-L-norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells.
- Published in:
- Oncology Letters, 2020, v. 20, n. 3, p. 3053
- By:
- Publication type:
- Article
A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells.
- Published in:
- Oncology Letters, 2019, v. 18, n. 6, p. 6909, doi. 10.3892/ol.2019.11008
- By:
- Publication type:
- Article
Genital association of human papillomavirus with and spp. in Mexican women with precancerous lesions.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0052754
- By:
- Publication type:
- Article
DNA Methylation-Independent Reversion of Gemcitabine Resistance by Hydralazine in Cervical Cancer Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0029181
- By:
- Publication type:
- Article
Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine.
- Published in:
- Journal of Translational Medicine, 2006, v. 4, p. 32, doi. 10.1186/1479-5876-4-32
- By:
- Publication type:
- Article
N -(2-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Induces Apoptosis and Cell Cycle Arrest in Breast Cancer Cells, Decreasing GPER Expression.
- Published in:
- Molecules, 2024, v. 29, n. 15, p. 3509, doi. 10.3390/molecules29153509
- By:
- Publication type:
- Article
Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84538-6
- By:
- Publication type:
- Article
Valproic acid inhibits interferon-γ production by NK cells and increases susceptibility to Listeria monocytogenes infection.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-74836-w
- By:
- Publication type:
- Article
Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study.
- Published in:
- 2007
- By:
- Publication type:
- Abstract
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.
- Published in:
- 2007
- By:
- Publication type:
- Abstract
A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer.
- Published in:
- 2007
- By:
- Publication type:
- Abstract
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes.
- Published in:
- BMC Cancer, 2005, v. 5, p. 44, doi. 10.1186/1471-2407-5-44
- By:
- Publication type:
- Article
HER2 expression in cervical cancer as a potential therapeutic target.
- Published in:
- BMC Cancer, 2004, v. 4, p. 59, doi. 10.1186/1471-2407-4-59
- By:
- Publication type:
- Article
Severe COVID‐19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin.
- Published in:
- Journal of Leukocyte Biology, 2021, v. 110, n. 3, p. 425, doi. 10.1002/JLB.4HI0221-087R
- By:
- Publication type:
- Article
The histone deacetylase inhibitor valproic acid attenuates phospholipase Cγ2 and IgE‐mediated mast cell activation.
- Published in:
- Journal of Leukocyte Biology, 2020, v. 108, n. 3, p. 859, doi. 10.1002/JLB.3AB0320-547RR
- By:
- Publication type:
- Article
Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer.
- Published in:
- Cancer Cell International, 2006, v. 6, p. 22, doi. 10.1186/1475-2867-6-22
- By:
- Publication type:
- Article
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines.
- Published in:
- Cancer Cell International, 2006, v. 6, p. 2, doi. 10.1186/1475-2867-6-2
- By:
- Publication type:
- Article
Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Valproic acid restricts mast cell activation by Listeria monocytogenes.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20054-5
- By:
- Publication type:
- Article
Antimetastatic Effect of Epigenetic Drugs, Hydralazine and Valproic Acid, in Ras-Transformed NIH 3T3 Cells [Corrigendum].
- Published in:
- OncoTargets & Therapy, 2022, v. 15, p. 845, doi. 10.2147/OTT.S382501
- By:
- Publication type:
- Article
Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 8823, doi. 10.2147/OTT.S187306
- By:
- Publication type:
- Article
Growth inhibition and transcriptional effects of ribavirin in lymphoma.
- Published in:
- Oncology Reports, 2019, v. 42, n. 3, p. 1248, doi. 10.3892/or.2019.7240
- By:
- Publication type:
- Article
Ribavirin as a tri-targeted antitumor repositioned drug.
- Published in:
- Oncology Reports, 2015, v. 33, n. 5, p. 2384, doi. 10.3892/or.2015.3816
- By:
- Publication type:
- Article
Prevalence of sexually transmitted pathogens associated with HPV infection in cervical samples in a Mexican population.
- Published in:
- Journal of Medical Virology, 2015, v. 87, n. 12, p. 2098, doi. 10.1002/jmv.24278
- By:
- Publication type:
- Article
TLR2 Regulates Mast Cell IL-6 and IL-13 Production During Listeria monocytogenes Infection.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.650779
- By:
- Publication type:
- Article
Ivermectin as an inhibitor of cancer stem-like cells.
- Published in:
- Molecular Medicine Reports, 2018, v. 17, n. 2, p. 3397, doi. 10.3892/mmr.2017.8231
- By:
- Publication type:
- Article